Zoetis Services LLC

Pfizer Corporation

Zoetis LLC

Pfizer Products Inc.

Zoetis P LLC

Pah USA 15 LLC

Richard Lee Krebs

Paul Joseph Dominowski

James Richard Thompson

Risini Dhammika Weeratna

Cedo Martin Bagi

Shucheng Zhang

Robert John Yancey, Jr

Mary Kathryn Olsen

Tedd Alan Childers

John Morgan Hardham

Duncan Mwangi

Dennis L Foss

Sharath K Rai

Suman Mahan

Shaunak Vora

Sangita Mediratta

Lauren Wilmes

Sarah A Salmon

Kaori Mohr

Ramasamy Mannar Mannan

Sandra Ann Marie Lightle

Guillermo Gallo

Ramasamy M Mannan

Pamela K Klose

Shelly Lynn Shields

Nancee Lois Oien

Joseph C Frantz

Mark D Goodyear

Michael John Huether

Robert Greg Sorensen

Laurel Mary Sly

Pamela Kay Klose

Robert John Yancey

Mark Davis Goodyear

Robert J Yancy

Martin Cedo Bagi

Corey Patrick Cook

Joseph Claude Frantz

David George Smith

William Donachie

Anita Dorota Jaglarz

Michael Christopher Fontaine

Julie Lydia Fitzpatrick

Sandra Ann Lightle

The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals.

Oil-based adjuvants

This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant compositions; and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens. This invention further relates to the use of the formulations in the treatment of animals.

Adjuvant compositions

Heat treated bacterins, a method of producing heat treated bacterins, and porcine emulsion vaccines prepared from such heat treated bacterins are disclosed.

Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

This invention provides submicron oil-in-water emulsions useful as a vaccine adjuvant for enhancing the immunogenicity of antigens. The present invention also provides vaccine compositions containing an antigen combined with such emulsions intrinsically or extrinsically. Methods of preparing the emulsions and vaccines are also provided by the present invention.

Microfluidized oil-in-water emulsions and vaccine compositions

This invention relates to vaccines and methods for protecting dogs against disease caused by. This invention also relates to combination vaccines and methods for protecting dogs against disease or disorder caused by canine pathogens, for example, infectious tracheobronchitis caused by, canine distemper caused by canine distemper (CD) virus, infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1), respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza (CPI) virus, enteritis caused by canine coronavirus (CCV) and canine parvovirus (CPV), and leptospirosis caused byor. The vaccines of the present invention include ap68 antigen.

Canine combination vaccines

Growing community of inventors

Ashland, NE, United States of America

Richard Lee Krebs